cDC1s contain the dead cell sensing receptor (DNGR-1), which inhibits tumor-infiltrating type I conventional dendritic cells and limits Flt3L-mediated anti-tumor immunity (88). The gene discussed is CLEC9A; the disease is neoplasm.